Gyeonggi-do, South Korea

Sookyung Jeong

This inventor holds 1 USPTO granted patent. Top assignee: Cha Vaccine Research Institute Co., Ltd. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sookyung Jeong. Retrieved from https://idiyas.com/inventor/sookyung-jeong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sookyung Jeong: Innovator in Vaccine Development

Introduction

Sookyung Jeong is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of vaccine research, particularly in the development of innovative adjuvants that enhance immune responses.

Latest Patents

Sookyung Jeong holds a patent for a "Vaccine adjuvant comprising lipopeptide-inserted liposome as effective ingredient and use thereof." This invention relates to a recombinant herpes zoster vaccine that utilizes liposomes and lipopeptides. The vaccine composition, prepared using Lipo-Pam, a composite adjuvant, effectively induces both cell-mediated and humoral immune responses. This advancement has the potential for commercial applications in vaccine development.

Career Highlights

Sookyung Jeong is affiliated with Cha Vaccine Research Institute Co., Ltd., where he continues to work on groundbreaking vaccine technologies. His research focuses on enhancing the efficacy of vaccines through innovative adjuvant formulations.

Collaborations

He collaborates with esteemed colleagues, including Jung Sun Yum and Hyun Jin Jo, who contribute to the research and development efforts at the institute.

Conclusion

Sookyung Jeong's work in vaccine innovation exemplifies the importance of research in public health. His contributions are paving the way for more effective vaccines that can significantly impact global health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…